Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 93-106

  Von Lubitz, Dag K J E ^a   Ye, Wen ^a   McClellan, Jennifer ^a   Lin, Rick C S ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BRAIN RECEPTOR; NITRIC OXIDE SYNTHASE; NITROGEN; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE;

APOPTOSIS; ARTHRITIS; ASTROCYTE; BRAIN INJURY; BRAIN ISCHEMIA; CONFERENCE PAPER; HEART MUSCLE ISCHEMIA; HIPPOCAMPUS; HUMAN; IMMUNOCYTOCHEMISTRY; MAST CELL DEGRANULATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; ANIMAL; DRUG POTENTIATION; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ADENOSINE; ANIMALS; BRAIN ISCHEMIA; MICE; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 0033233390     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07984.x     Document Type: Conference Paper

References (75)

1. 1. Mykrhof, W.R., R. Müller-Brechlin & D. Richter. 1991. Molecular cloning of a novel putative G protein-coupled receptor expressed during rat spermiogenesis. FEBS Lett. 284: 155-160.
2. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89: 7432-7436.
3. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 44: 524-532.
4. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 90: 10365-10369.
5. 3 receptors: design of selective ligands and therapeutic prospects. Drugs Future 20: 689-699.
6. 6. Van Rhee A.M. & K.A. Jacobson. 1996. Molecular architecture of G-protein coupled receptor. Drug. Dev. Res. 37: 1-38.
7. 3 receptor. J. Biol. Chem. 28: 16895-16902.
8. 8. Palmer, T.M. & G.L. Stiles. 1997. Structure-function analysis of inhibitory adenosine receptor regulation. Neuropharamacology 36: 1141-1147.
9. 3 receptor. J. Biol. Chem. 270: 29607-29613.
10. 10. Olah, M.E. & G.L. Stiles. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35: 581-606.
11. 3 receptors in rat brain. Mol. Pharmacol. 48: 1038-1045.
12. 3 AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268: 16887-16890.
13. 3 receptor. Ann. N.Y. Acad. Sci. 825: 11-22.
14. 3 receptor and brain: a culprit, a hero, or merely yet another receptor? Ann. N.Y. Acad. Sci. 825: 49-67.
15. 1 receptor-mediated responses in rat hippocampus. J. Neurosci. 17: 807-814.
16. 3 adenosine receptors. Drug Dev. Res. 33: 51-59.
17. 3 adenosine antagonists: structural homology and receptor dockling. J. Chem. Inf. Compul. Sci. 38: 1239-1248.
18. 3 adenosine receptor agonists. J. Med. Chem. 41: 3174-3185.
19. 3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives. J. Med. Chem. 41: 3987-3993.
20. 3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds. J. Med. Chem. 41: 3994-4000.
21. 3 adenosine receptor. Circ. Res. 78: 627-634.
22. 3-subtype adenosine receptor is highly expressed in rat vascular smooth muscel cells: its role in attenuating adenosine-induced increases in cAMP. Microvasc. Res. 54: 243-252.
23. 3 receptor agonist 2-Cl-IB-MECA in conscious rats. Eur. J. Pharmacol. 308: 311-314.
24. 3 receptors. J. Immunol. 11: 5400-5008.
25. 3 receptors during prolonged simulated ischemia. J. Physiol. 273 (Heart Circ. Physiol. 42): H501-505.
26. 3 receptor. FASEB J. 12: 1785-1792.
27. 3 receptor: sustained cardioprotection. Proc. Natl. Acad. Sci. USA 95: 6995-6999.
28. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc. Res. (Netherl.) 33: 410-415.
29. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J. Mol. Cell. Cardiol. 30: 579-585.
30. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res. 28: 1057-1061.
31. 2 receptor activation. Circ. Res. 81:415-422.
32. 32. Szabo, C., G.S. Scott, L. Virag, G. Egnaczyk, A.L. Salzman, T.P. Hanley & G. Hasko. 1998. Suppression of macrophage inflammatory protein (MIP)-1α production and collagen-induced arthritis by adenosine receptor agonists. Br. J. Pharmacol. 125: 379-387.
33. 3 receptors on macrophages inhibits tumor necrosis factor-alpha. Eur. J. Pharmacol. 310(2-3): 209-216.
34. 3 receptor agonists inhibit murine macrophage tumor necrosis factor-α production in vitro and in vivo. Cell. Mol. Biol. 43: 345-349.
35. 3 receptor stimulation inhibits migration of human eosinophils. J. Leukocyte Biol. 62: 465-468.
36. 3 receptor expression and function in eosinophils. Am. J. Respir. Cell Mol. Biol. 16: 531-537.
37. 3 receptors potentiate hippocampal calcium by a PKA-dependent/PKC-independent pathway. Neuropharmacology 36: 353-362.
38. 38. Domanska-Janik, K. 1996. Protein serine/threonine kinases (PKA, PKC, and CaMKII) involved in ischemic brain pathology. Acta Neurobiol. Exp. 2: 579-585.
39. 3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J. Neurosci. 18: 6136-6146.
40. 40. Glaum, S.R. & R.J. Miller. 1994. Acute regulation of synaptic transmission by metabotropic glutamate receptors. In The Metabotropic Glutamate Receptors. P.J. Conn & J. Patel, Eds.: 147-172. Humana Press. Tatawa, NJ.
41. 2: studies in human astroglioma cells. Biochem. Biophys. Res. Commun. 241(2): 297-304.
42. 3 antagonists. Biochem. Biophys. Res. Commun. 232: 317-322.
43. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263: 59-67.
44. 3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons. Drug Dev. Res. 40: 267-273.
45. 3 receptor agonist and cerebral ischemia: neuronal and glial effects. Eur. J. Pharmacol. In press.
46. 3 receptor antagonists and protection against cerebral ischemia [abstract 745.16]. Soc. Neurosci. Abstr. 23/2: 1924.
47. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88: 3569-3574.
48. 48. Yamasaki, Y., Y. Itoyama & K. Kogure. 1996. Involvement of cytokine production in pathogenesis of transient cerebral ischemic damage. Keio J. Med. 3: 225-229.
49. 49. Hallenbeck, J.M. 1996. Significance of the inflammatory response in brain ischemia. Acta Neurochir. Suppl. 66: 27-31.
50. 50. Stoll, G., S. Jander & M. Schroeter. 1998. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56: 149-171.
51. 51. Louw, D.F., T. Masada & G.R. Sutherland. 1998. Ischemic neuronal injury is ameliorated by astrocyte activation. Can. J. Neurol. Sci. 25: 102-107.
52. 52. Petito, C.K., J.P. Olarte, B. Roberta, T.S. Nowak, Jr & W.A. Pulsinelli. 1998. Selective glial vulnerability following transient global ischemia in rat brain. J. Neurobiol. Exp. Neurol. 57: 231-238.
53. 53. Ballarin, M., B.B. Fredholm, S. Ambrosi & N. Mahy. 1991. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand. 142: 97-103.
54. 54. Whittingham, T.S. 1990. Aspects of brain energy metabolism and cerebral ischemia. In Cerebral Ischemia and Resuscitation. A. Schurr & B.M. Rigor, Eds.: 101-121. CRC Press. Boca Raton, FL.
55. 55. Hagberg, H., P. Andersson, J. Lacarewicz, I. Jacobson, S. Butcher & M. Sandberg. 1987. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49: 227-231.
56. 56. Phillis, J.W. 1990. Adenosine, inosine, and oxypurines in cerebral ischemia. In Cerebral Ischemia and Resuscitation. A. Schurr & B.M. Rigor, Eds.: 189-204. CRC Press. Boca Raton, FL.
57. 57. Bell, M.J., P.M. Kochanek, J.A. Carcillo, Z. Mi, J.K. Schiding, S.R. Wisniewski, R.S.B. Clark, C.E. Dixon, D.W. Marion & E. Jackson. 1998. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma 15(3): 163-170.
58. 58. von Lubitz, D.K.J.E. 1999. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. In press.
59. 59. von Lubitz, D.K.J.E. & P.J. Marangos. 1990. Self-defense of the brain: adenosinergic strategies in neurodegeneration. In Emerging Strategies in Neurodegeneration. P.J. Marangos & H. Lal, Eds.: 151-186. Birkhauser. Boston.
60. 60. Fredholm, B.B. 1997. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40: 259-280.
61. 61. Rudolphi, K.A., P. Schubert, F.E. Parkinson & B.B. Fredholm. 1992. Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4: 346-369.
62. 62. von Lubitz, D.K.J.E. 1997. Acute treatment of cerebral ischemia and stroke: put out more flags. In Purinergic Approaches in Experimental Therapeutics. K.A. Jacobson & M.F. Jarvis, Eds.: 449-470. Wiley-Liss. New York.
63. 63. Matsumoto, K., R. Graf, G. Rosner, N. Shimada & W.D. Heuiss. 1992. Flow thresholds for extracellular purine catabolite elevation in cat brain ischemia. Brain Res. 579: 309-314.
64. 64. Astrup, J., B.K. Siesjö & L. Symon. 1981. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 12: 723-725.
65. 2+ frequency depends on endogenous adenosine. Int. J. Purine Pyrimidine Res. 2: 11-16.
66. 66. Hoehn, K. & T.D. White. 1990. N-Methyl-D-aspartate, kainate, and quisqualate release endogenous adenosine from rat cortical slices. J. Neurochem. 54.
67. + and glutamate-evoked release of endogenous adenosine from rat cortical slices. J. Neurochem. 54: 256-265.
68. 68. Delaney, S.M. & J.D. Geiger. 1998. Levels of endogenous adenosine in rat striatum II: regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism. J. Exp. Pharmacol. Ther. 285: 568-572.
69. 69. Cronstein, B. 1997. Adenosine regulation of neutrophil function and inhibition of inflammation via adenosine receptors. In Purinergic Approaches in Experimental Therapeutics. K.A. Jacobson & M.F. Jarvis, Eds.: 285-299. Wiley-Liss. New York.
70. 70. Swanson, R.A., K. Farell & R.P. Simon. 1995. Acidosis causes failure of astrocyte glutamate uptake during hypoxia. J. Cereb. Blood Flow Metab. 3: 417-424.
71. 71. Conti, A.C., R. Raghupathi, J.Q. Trojanowski & T.K. McIntosh. 1998. Experimental brain injury induces regionally distinct apoptosis during acute and delayed posttraumatic period. J. Neurosci. 18: 5663-5672.
72. 72. Hu, J. & D.J. van Eldik. 1996. S100-ß induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochem. Biophys. Acta 131: 239-245.
73. 73. Bonfoco, E., M. Leist, B. Zhivotovsky, S. Orrenius, S.A. Lipton & P. Nicotera. 1996. Cytoskeletal breakdown and apoptosis elicited by NO donors in cerebellar grunule cells require NMDA receptor activation. J. Neurochem. 67: 2484-2493.
74. 74. Nomura, Y., T. Uehara & M. Nakazawa. 1996. Neuronal apoptosis by glial NO: involvement of inhibition af glyceraldehyde 3-phosphate. Hum. Cell 9: 205-214.
75. 75. Newby, A.C. 1984. Adenosine and the concept of "retaliatory metabolites." Trends Pharmacol. Sci. 9: 42-48.